–

DAY 1 – TUESDAY 9 MARCH 2027

12:00-13:00  Registration

Opening

13:00-13:10  Welcome. Mariona Graupera, Chair of the Scientific Committee

13:10-13:20  Patient representatives’ message

13:20-13:30  Patient testimonies

Keynote Lecture I

13:30-14:15  Clinical Management of patients with vascular anomalies. Beth Drolet (USA)

 

Session 1 – Venous Malformations

14:15-14:40  TALK: New models for the study of venous malformations. Elisa Boscolo (USA)

14:40-14:55  SHORT TALK 1

14:55-15:10  SHORT TALK 2

15:10- 15:40 Coffee break

15:40-16:05  TALK: Embryonic development errors driving venous malformations. Ana Angulo-Urarte (IJC, Spain)

16:05-16:20  SHORT TALK 3

16:20-16:35  SHORT TALK 4

16:35-17:00  TALK: New genetic insights on venous malformations. Sarah Sheppard –

17:00-17:15  SHORT TALK 5

17:15-17:30  SHORT TALK 6

17:30-18:10  Flash Talks 1: 6 short talks, 5 min each + 10min discussion

Welcome Drink

18:10-19:30  Networking drink

 

DAY 2 – WEDNESDAY 10 MARCH 2027

Keynote Lecture II

13:30-14:15  – Genetic and environmental determinants on vascular anomalies Claire Shovlin

Session 2 – Lymphatic Malformations & Lymphedema

09:30-09:40  Patient Testimonies

09:40-10:05  TALK: Endothelial cell dynamics in lymphatic malformations. Taija Makinen (Finland)

10:05-10:20  SHORT TALK 7        

10:20-10:35  SHORT TALK 8        

10:35-11:00  TALK: Understanding complex lymphatic anomalies. Michael Dellinger

11:00-11:30  Coffee break

11:30-11:55  TALK: Treatments for kaposiform lymphangiomatosis. Shoshana Greenberger (Israel)

11:55-12:10  SHORT TALK 9        

12:10-12:25  SHORT TALK 10     

12:25-13:25  Lunch

13:15-14:45  POSTER SESSION I

14:45-15:00  Patient Testimonies 

15:00-15:25  TALK: Clinical management of patients with congenital lymphedema. Isabelle Quere

15:25-15:40  SHORT TALK 11     

15:40-15:55  SHORT TALK 12     

15:55-16:35  Flash Talks 2: 6 short talks, 5 min each + 10min discussion    

16:35-17:05  Coffee break     

17:05-17:30  TALK: Latest advances in lymphedema. Pia Ostergaard

17:30-17:45  SHORT TALK 13     

17:45-18:00  SHORT TALK 14     

18:00-18:30  ROUND TABLE: Round table with patients, clinician and researcher

Cultural activity

18:30-20:30  Guided Walking Tour: Gothic Quarter and Born

 

DAY 3 – THURSDAY 11 MARCH 2027

08:00-08:45  MEET SPEAKERS: Breakfast with the speakers

Keynote Lecture III

08:45-09:30  Novel iPSC models for the study of vascular diseases. Josef Penninger

Session 3 – Arteriovenous Malformations & HHT

09:30-09:55  TALK: Hemodynamic stress in arteriovenous malformations. Claudio Franco (Portugal)

09:55-10:10  SHORT TALK 15     

10:10-10:35  TALK: The latest on BMP signalling in HHT. Sabine Bailly

10:35-11:05  Coffee break

11:05-11:30  TALK: How to approach therapeutic interventions in arteriovenous malformations. Julien Coulie

11:30-11:45  SHORT TALK 16     

11:45-12:00  SHORT TALK 17     

12:00-12:15  Patient Testimonies             

12:15-13:15  Lunch

13:15-14:45  POSTER SESSION II

Session 4 – Clinical Trials

14:45-15:10  TALK: Clinical trials on PI3K-related syndromes Paloma Triana (Spain)

15:10-15:25  SHORT TALK 18     

15:25-15:40  SHORT TALK 19     

15:40-16:10  Coffee break

16:10-16:35  TALK  – AKT inhibitors for management of patients with HHT. Antoni Riera-Mestre (Spain)

16:35-17:00  TALK: Molecular therapies for arteriovenous malformations. Laurence Boon (Belgium)

17:00-17:15  SHORT TALK 20     

VAC Dinner

20:00  Dinner & Networking

 

DAY 4 – FRIDAY 12 MARCH 2027

 

Session 5 – Capillary malformations

 

09:00-9:25    TALK: Genotypes and phenotypes of capillary malformations. Eulalia Baselga (HSJD, Spain)

09:25-09:40  SHORT TALK 21     

09:40-09:55  SHORT TALK 22     

09:55-10:10  SHORT TALK 23     

10:10-10:35  TALK: Cerebral capillary malformations caused by activating GNAQ signalling. Ayal Ben-Zvi (Israel)

10:35-10:50  Patient Testimonies             

10:50-11:20  Coffee break

Session 6 – Cerebral Cavernous Malformations (CCM) & Brain Lesions

11:20-11:45  TALK: Novel therapeutic approaches for CCM. Michael Potente (Germany)

11:45-12:10  TALK: Genetic basis of sporadic CCMs. Mark Khan (USA)

12:10-12:25  SHORT TALK 24      Selected from Abstracts

12:25-12:40  SHORT TALK 25      Selected from Abstracts

12:40-13:05  TALK: The latest on cerebral small vessel diseases (SVD). Anne Joutel (France)

Awards & Closing

13:05-13:15  Awards & Closing